PERIPARTIAL CARDIOMYOPATHY AS A RISK FACTOR FOR AN UNFAVORABLE COURSE OF THE GESTATIONAL PERIOD
Abstract
At present, diseases of the cardiovascular system in developed countries remain the main cause of death in middleaged
and elderly people. Women have a worse prognosis for cardiovascular disease than men: more women die from
their first myocardial infarction, and also during the first year of life after a heart attack, but for many years women
were excluded from research on cardiovascular diseases. Recent studies have revealed a new nosological form of
complicated pregnancy and the first months of the postpartum period, which affects maternal mortality. However,
information concerning this pathology is contradictory, and the existing sources are mainly characterized by
descriptive content.
References
Ватутин, Н.Т. Современные представления
о перипартальной кардиомиопатии (часть I):
определение, эпидемиология, патогенез /
Н.Т.Ватутин, Г.Г.Тарадин, С.М.Корниенко [и
др.] // Российский кардиологический журнал, –
, – №115, с. 76-82
Halkein, J. Micro RNA-146a is a therapeutic
target and biomarker for peripartum
cardiomyopathy / J.Halkein, S.P.Tabruyn,
M.Ricke-Hoch [et al.] // J. Clin. Invest., – 2013,
, – p.2143-2154.
Королева, Е.Б., Востокова, А.А. Перипар-
тальная кардиомиопатия. Диагноз, прогноз,
значение для материнской смертности //
Медицинский Альманах, – 2009, №4, – с.82-86
Кузнецов, Г.П. Перипартальная kardiomiopatiya.
Cовременное состояние проблемы //
Новости медицины и фармации, – 2014, №1-2,
– с.10-13.
Мостбауер, Г.В. Перипартальная (послеродо-
вая) кардиомиопатия // Therapia, – 2010, №45,
– с.28-32.
Frustaci, A., Cimenti, C., Taradin, G.G. The
role of immunity suppression in treatment of
myocarditis // Russian Journal of Cardiology, –
, 2, – p.114-118.
Arany, Z., Elkayam, U. Peripartum cardiomyopathy
// Circulation, – 2016, 133(14), – p.1397
-409
Лукьянов, В.Ф., Головачева, Т.В., Лукьянова,
С.В. Сосудистая резистентность при гиперто-
нической болезни: соотношение общего
периферического и регионарного сосудистого
сопротивления // Российский кардиологи-
ческий журнал, – 2001, № 3, – с.20-24
Bachelier-Walenta, K., Hilfiker-Kleiner, D,
Sliwa, K. Peripartum cardiomyopathy: 2012 // Curr
Opin Crit Care, – 2013, 19, – p.397-403
Haghikia, A. Phenotyping and outcome on
contemporary management in a German cohort of
patients with peripartum cardiomyopathy /A.Haghikia, E.Podewski, E.Libhaber, [et al.] //
Basic. Res. Cardiol. – 2013, 108(4), – р. 366.
Bauersachs, J. Current management of patients
with severe acute peripartum cardiomyopathy:
practical guidance from the Heart Failure
Association of the European Society of Cardiology
Study Group on peripartum cardiomyopathy /
J.Bauersachs, M.Arrigo, D.Hilfiker-Kleiner [et
al.] // Eur J Heart Fail., – 2016, 18(9), – p.1096-
Bhattacharyya A., Basra S.S., Sen P., Kar B.
Peripartum cardiomyopathy: a review // Tex Heart
Inst J. – 2012, 39(1), – p.8-16
Jeanneteau, P. Bromocriptine-induced coronary
spasm in postpartum / P.Jeanneteau, L.Bière,
M.Mercier [et al.] // Eur. J. Obstet. Gynecol.
Reprod. Biol., – 2014, 179, – p.258-259
Lamparter, S, Pankuweit, S, Maisch, B.
Clinical and immunological characteristics in
peripartum cardiomyopathy // Int. J. Cardiol., –
, 118, – p.14-20
Кузнецов, Г. Перипартальная кардио-
миопатия // Медицинская газета, – 2013, №80, –
с.8-9
Elkayam, U. High-risk cardiac disease in
pregnancy / U.Elkayam, S.Goland, P.Pieper [et
al.] // Part II. J Am Coll Cardiol., – 2016, 68, –
p.502-516
Davis, M., Duvernoy, C. Peripartum
cardiomyopathy: current knowledge and future
directions // Womens Health (Lond), – 2015, 11
(4), – p.565-573
Fett, J.D. Cabergoline in the treatment of
peripartum cardiomyopathy // Rev. Bras. Ginecol.
Obstet., – 2016, 38(8), – p.423-424
Briggs, G.G., Freeman, R.K., Yaffe, S.J. Drugs
in pregnancy and lactation, 9th edn, Baltimore:
Williams & Wilkins, – 2011. – 1728 p.
Chaggar, P.S., Shaw, S.M., Williams, S.G. Is
foxglove effective in heart failure? // Cardiovasc.
Ther., – 2015, 33, – p.236–241.
Demakis J.G., Rahimtoola S.H. Peripartum
cardiomyopathy // Circulation, – 1971, 44, – p.964
-968
Huisman, C.M. Incidence and predictors of
maternal cardiovascular mortality in the
Netherlands: a prospective cohort study /
C.M.Huisman, J.J.Zwart, J.W.Roos-Hesselink [et
al.] // PLoS ONE. – 2013, 8
Sliwa, K. The addition of pentoxifylline to
conventional therapy improves outcome in patients
with peripartum cardiomyopathy / K.Sliwa,
D.Skudicky, G.Candy [et al.] // Eur. J. Heart Fail.,
– 2002, 4(3), – p.305-309
Keywords
gestational age
risk factor
early estrogen deficiency Портальная кардиомиопатия
гестационный возраст
фактор риска
ранний дефицит эстрогенов Portal kardiomiopatiya
hestasiya dövrü
risk faktoru
erkən estrogen çatışmazlığı